Patents by Inventor Daniela Boehm

Daniela Boehm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11807852
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: November 7, 2023
    Assignee: The J. David Gladstone Institutes
    Inventors: Melanie Ott, Daniela Boehm
  • Publication number: 20220090085
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Application
    Filed: July 20, 2021
    Publication date: March 24, 2022
    Inventors: Melanie Ott, Daniela Boehm
  • Patent number: 11098309
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: August 24, 2021
    Assignee: The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone
    Inventors: Melanie Ott, Daniela Boehm
  • Publication number: 20190338289
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 7, 2019
    Inventors: Melanie Ott, Daniela Boehm
  • Patent number: 10351853
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: July 16, 2019
    Assignee: The J. David Gladstone Institutes
    Inventors: Melanie Ott, Daniela Boehm
  • Publication number: 20180002699
    Abstract: The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
    Type: Application
    Filed: April 14, 2017
    Publication date: January 4, 2018
    Inventors: Melanie Ott, Daniela Boehm